This study further proved the anti-neuroinflammatory effects of savinin at the in vivo level for the first time, that is, savinin inhibits brain inflammation, and these effects are related to both MAPK/NF-κB and NLRP3 pathways. The gene discussed is NLRP3; the disease is brain inflammatory disease.